Literature DB >> 11532575

Application of linear mixed effects models to the evaluation of dissolution profiles.

E Adams1, D Coomans, J Smeyers-Verbeke, D L Massart.   

Abstract

The performance of linear mixed effects models for the comparison of dissolution profiles is examined. This type of model is frequently used by statisticians, but is rather unknown to people that work in dissolution laboratories. Hence, an extensive theoretical part was introduced to make the methodology more accessible. Firstly, repeated measures ANOVA is discussed, followed by the "real" linear mixed effects models. The theory is applied to two types of dissolution data: one corresponding to an immediate and another to a slow release formulation. We tried to use as much as possible the standard settings of the statistical software (S-plus). Suggestions are given to solve problems encountered during model fitting. It was found that the statistical limits are much more discriminative than the similarity factor.

Entities:  

Mesh:

Year:  2001        PMID: 11532575     DOI: 10.1016/s0378-5173(01)00775-x

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  4 in total

1.  DDSolver: an add-in program for modeling and comparison of drug dissolution profiles.

Authors:  Yong Zhang; Meirong Huo; Jianping Zhou; Aifeng Zou; Weize Li; Chengli Yao; Shaofei Xie
Journal:  AAPS J       Date:  2010-04-06       Impact factor: 4.009

2.  Dissolution comparisons using a Multivariate Statistical Distance (MSD) test and a comparison of various approaches for calculating the measurements of dissolution profile comparison.

Authors:  J-M Cardot; B Roudier; H Schütz
Journal:  AAPS J       Date:  2017-03-28       Impact factor: 4.009

3.  Rehydrated sterically stabilized phospholipid nanomicelles of budesonide for nebulization: physicochemical characterization and in vitro, in vivo evaluations.

Authors:  Mohanad Naji Sahib; Yusrida Darwis; Kok Khiang Peh; Shaymaa Abdalwahed Abdulameer; Yvonne Tze Fung Tan
Journal:  Int J Nanomedicine       Date:  2011-10-14

4.  Comparison between the dissolution profiles of nine meloxicam tablet brands commercially available in Buenos Aires, Argentina.

Authors:  Laura D Simionato; Luciana Petrone; Mariela Baldut; Silvina L Bonafede; Adriana Inés Segall
Journal:  Saudi Pharm J       Date:  2018-02-09       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.